Posted on 8/17/20
Anthem and Quest Diagnostics Form Strategic Relationship
Anthem Inc. (NYSE: ANTM) and Quest Diagnostics (NYSE: DGX) have entered into a strategic relationship by collaborating on a variety of outcomes-based programs designed to create . . .
Posted on 8/17/20
2 Forever Pharma Stocks to Buy Now
Patients need access to medicine to treat or manage serious health conditions, no matter what state the economy is in. Drugs are effectively a recession-proof business. . . .
Posted on 8/17/20
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Which of Pfizer's (NYSE:PFE) products grab investors' attention the most? I'd put BNT162b2, the COVID-19 vaccine candidate that Pfizer is developing with BioNTech, high on the . . .
Posted on 8/17/20
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
How could you make a lot of money? Buy shares of a company that isn't profitable yet and doesn't even have consistent revenue. Hold onto those . . .
Posted on 8/17/20
Is Inovio Pharmaceuticals a Good Coronavirus Stock to Buy?
There have been more than 20 million coronavirus cases and 749,000 COVID-19-related deaths worldwide. The U.S. alone has recorded 5 million cases and 169,000 related deaths. . . .
Posted on 8/17/20
Caladrius Biosciences Provides Corporate Update
BASKING RIDGE, N.J., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 8/17/20
Optinose Proposes Public Offering of Common Stock
YARDLEY, Pa., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, today . . .
Posted on 8/17/20
Optinose Prices Public Offering of Common Stock
YARDLEY, Pa., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, today . . .
Posted on 8/17/20
OncoSec Medical Announces Proposed Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ: ONCS) announced that it intends to offer and sell shares of its common stock in a public offering. The offering is subject . . .
Posted on 8/17/20
Interview with Babak Movassaghi, CEO at InfiniteMD
Telehealth is certainly a complex and evolving industry, especially over the past few months. Due to COVID-19, now more than ever, elite clinical teams are being sought . . .
Posted on 8/14/20
PLx Pharma Reports Second Quarter 2020 Results and Provides Business Update
SPARTA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard . . .
Posted on 8/14/20
Is Johnson & Johnson a Great Dividend Stock?
Most pharmaceutical companies out there are working hard to win the coronavirus vaccine race. Pharma and consumer goods giant Johnson & Johnson (NYSE:JNJ) is among them.But . . .
Posted on 8/14/20
Is Inovio Pharmaceuticals Stock a Buy?
Investing in clinical-stage biotech companies isn't for the faint of heart. Negative results from clinical trials or regulatory roadblocks can send shares of these companies plunging. . . .
Posted on 8/14/20
What's the Outlook for Inovio Pharmaceuticals Stock?
As of Monday, more than 20 million cases of COVID-19 have been confirmed worldwide, and close to 740,000 deaths have been attributed to it -- and . . .
Posted on 8/13/20
Children's Dental Management Named as One of Inc. Magazine's 5000 Fastest-Growing Private Companies
Children's Dental Management, a leading Dental Support Organization (DSO), was named to Inc. magazine's annual Inc. 5000 list with a rank of 2993. The Inc. 5000 . . .
Posted on 8/13/20
BioNTech and Pfizer Hope to Have Late-Stage Coronavirus Vaccine Results by October
On Tuesday, BioNTech (NASDAQ:BNTX) confirmed what its big pharma partner, Pfizer (NYSE:PFE), had already let out of the bag: The companies hope to have phase 3 . . .
Posted on 8/12/20
Caregility and Iron Bow Healthcare Solutions Announce Partnership
Caregility, a clinical collaboration and communications company moving the access point of care closer to the patient, announces a partnership with Iron Bow Healthcare Solutions, a . . .
Posted on 8/12/20
Trevena Prices $50M Public Offering
CHESTERBROOK, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with . . .
Posted on 8/12/20
Bristol Myers Squibb and the Bristol Myers Squibb Foundation Commit $300 Million to Accelerate and Expand Health Equity and Diversity and Inclusion Efforts
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) and the Bristol Myers Squibb Foundation announced today a combined investment of $300 million as part of a series . . .
Posted on 8/12/20
States with the Most Improved Health During COVID-19 – WalletHub Study
With states’ reopening progress being delayed due to spikes in COVID-19, WalletHub today released updated rankings for the States with the Biggest Health Improvements During COVID-19, . . .
Posted on 8/12/20
Stock Markets Take Late-Day Hit; Inovio, Novavax Plunge on Coronavirus Vaccine Concerns
On Wall Street, it seemed as though Tuesday would be a repeat of Monday, with strength in the Dow Jones Industrial Average (DJINDICES:^DJI) coupled with weakness . . .
Posted on 8/12/20
Should Pfizer Be Your Next Coronavirus Buy?
The coronavirus pandemic has the world's drugmakers working together to deliver medical solutions and some companies are poised to contribute more than others. With a coronavirus . . .
Posted on 8/12/20
BioNTech and Pfizer Hope to Have Late-Stage Coronavirus Vaccine Results by October
On Tuesday, BioNTech (NASDAQ:BNTX) confirmed what its big pharma partner, Pfizer (NYSE:PFE), had already let out of the bag: The companies hope to have phase 3 . . .
Posted on 8/12/20
IPO Update: Harmony Biosciences Seeks $100 Million IPO
SummaryHarmony Biosciences intends to raise $100 million in an IPO.The firm is developing and commercializing treatments for narcolepsy and related conditions.HRMY has shown a strong revenue . . .
Posted on 8/12/20
Osmotica Pharmaceuticals Provides Business Updates
BRIDGEWATER, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced business highlights and financial results for . . .
Philadelphia
